ADL Data Systems > NewsBlog > Compliance

Compliance

ADL Passes EPCS Re-Certification

2 October 2019
Olinda Montoro
No comments
Categories: ADL News

ADL Data Passes DEA EPCS Re-Certification

The re-certification extends authorization to use DEA EPCS Certificates for another two years and allows physicians to use their Smartphone to comply with the required 2-Factor Authentication. This eliminates the need to carry a separate FOB or Id Cards.

A copy of the report has been posted on the ADL Website: EMR Certifications.

Approved Certification Process: //www.deadiversion.usdoj.gov/ecomm/e_rx/thirdparty.htm

Verify Physicians DEA Registration: //apps.deadiversion.usdoj.gov/webforms/validateLogin.jsp

EMR Updates for CMS New Patient Driven Payment Module (PDPM)

10 June 2019
Olinda Montoro
No comments
Categories: ADL News, CMS Announcements

Announcing Major Functionality Enhancements to ADL Optimum Series EMR

ADL is enhancing its software in preparation for the Patient Driven Payment Module (PDPM). Our goal is to assist facility staff in classifying patients into the appropriate payment groups based on data driven clinical characteristics. PDPM is value based and rewards patient outcomes.

Patient Driven Payment Method (PDPM) Information

Effective October 01, 2019, each patient will be assigned a case mix classification that drives reimbursement. The primary diagnosis (Section I10020B on the MDS) will determine which of the 10 clinical categories the patient will be assigned. Once the clinical category and any comorbidities are taken into account, the patient will be categorized further based on 5 criteria: Nursing, Occupational Therapy, Physical Therapy, Speech Therapy, Non Therapy Ancillary (NTA). These 5 items are the basis of PDPM.

Prepare for PDPM Now:

Things to Review with Staff
1 Ensure staff is proficient in ICD-10 coding and that all codes are accounted for appropriately.
ADL software will display appropriate Diagnosis codes throughout the EMR
2 Make sure relevant staff is familiar with Section GG of the MDS
3 Calculates a residents LACE score to predict the rate of readmission or death within 30 days of discharge
4 Make sure comorbidities are captured upon admission
5 Make sure HIV/AIDS codes are accurate for the increased rate adjustment
6 Reduce burden of multiple assessments – Scheduled MDS assessments will decrease from a minimum of 5 in 100 day stay
to 1 completed at the beginning of care
7 MDS I8000 Active Diagnosis – Make sure to capture accurate and detailed medical diagnosis
8 PDPM scores will be accessible within various places in the EMR as reference

Compliance Requirements
1 MDS new category I10020B for Primary Diagnosis will determine clinical categories
2 Providers will be required to complete an IPA with an ARD by 10/07/2019 for all Medicare Part A residents
(10/01/19 is Day 1 so schedule accordingly)
3 Each should discipline justify and support the level of service provided.
ADL will alert user when assessments are due and ensure that proper ICD-10 codes are used based on conditions and orders
4 Re-certification tracker of all active ICD-10 codes will keep you in compliance

For more information, reference the CMS official website here.

EPCS Waivers Guidance

8 April 2016
ephraim fuchs
No comments
Categories: ADL News
March 18, 2016
New York Electronic Prescribing Waivers Guidance for Specific Types of Prescriptions The New York Department of Health, pursuant to questions received from NCPDP members as well as other industry stakeholders, has released guidance as to how to handle specific types of prescriptions that currently are not well suited to electronic prescribing. Said guidance waives, until March 27, 2017, the requirement that these specific prescription types be electronically prescribed as required by New York’s  iSTOP law. The key portion of this guidance is reproduced below. The New York Commissioner of Health, in a letter, has waived the following circumstances from the requirements of electronic prescribing:

  1. Any practitioner prescribing a controlled or non-controlled substance, containing two (2) or more products, which is compounded by a pharmacist.
  2. Any practitioner prescribing a controlled or non-controlled substance to be compounded for the direct administration to a patient by parenteral, intravenous, intramuscular, subcutaneous or intraspinal infusion.
  3. Any practitioner prescribing a controlled or non-controlled substance that contains long or complicated directions.
  4. Any practitioner prescribing a controlled or non-controlled substance that requires a prescription to contain certain elements required by the federal Food and Drug Administration (FDA) that are not able to be accomplished with electronic prescribing.
  5. Any practitioner prescribing a controlled or non-controlled substance under approved protocols under expedited partner therapy, collaborative drug management or in response to a public health emergency that would allow a non-patient specific prescription.
  6. Any practitioner prescribing an opioid antagonist that would allow a non-patient specific prescription.
  7. Any practitioner prescribing a controlled or non-controlled substance under a research protocol.
  8. A practitioner prescribing a controlled or non-controlled substance either through an Official New York State Prescription form or an oral prescription communicated to a pharmacist serving as a vendor of pharmaceutical services, by an agent who is a health care practitioner, for patients in nursing homes and residential health care facilities as defined in section twenty-eight hundred one of the public health law.
  9. A pharmacist dispensing controlled and non-controlled substance compounded prescriptions, prescriptions containing long or complicated directions, and prescriptions containing certain elements required by the FDA or any other governmental agency that are not able to be accomplished with electronic prescribing.
  10. A pharmacist dispensing prescriptions issued under a research protocol, or under approved protocols for expedited partner therapy, or for collaborative drug management.
  11. A pharmacist dispensing non-patient specific prescriptions, including opioid antagonists, or prescriptions issued in response to a public health emergency issued.
  12. A pharmacist serving as a vendor of pharmaceutical services dispensing a controlled or non-controlled substance through an Official New York State Prescription form or an oral prescription communicated by an agent who is a health care practitioner, for patients in nursing homes and residential health care facilities as defined in section twenty-eight hundred one of the public health law.Practitioners issuing prescriptions in the above-listed exceptional circumstances may either use the Official New York State Prescription Form or issue an oral prescription. Pharmacists may dispense prescriptions issued on the Official New York State Prescription Form or oral prescriptions in the above-listed exceptional circumstances.

This waiver for the above-listed exceptional circumstances shall be effective until March 27, 2017.

ADL Certified for NCPDP 10.6 Electronic Pharmacy Transmissions

6 November 2014
ephraim fuchs
No comments
Categories: ADL News, CMS Announcements

As of November 1, 2014, the Centers for Medicare and Medicaid Services (CMS) effected their mandate requiring long-term care providers to conduct electronic pharmacy transmissions via the National Prescription Drug Programs (NCPDP) 10.6 Script protocol.

ADL has been certified by pharmacy software vendors to be in compliance with the new protocol.

 
 
 
 
 
 
 
 
 
 

Search

Recent Posts